Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rib Fractures | 1 | 2015 | 27 | 0.470 |
Why?
|
| Pseudomonas Infections | 2 | 2016 | 122 | 0.460 |
Why?
|
| Cartilage | 1 | 2015 | 51 | 0.460 |
Why?
|
| Thoracic Wall | 1 | 2015 | 40 | 0.450 |
Why?
|
| Fracture Fixation, Internal | 1 | 2015 | 83 | 0.450 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2015 | 109 | 0.410 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2016 | 180 | 0.370 |
Why?
|
| Pneumonia, Bacterial | 1 | 2012 | 81 | 0.360 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2012 | 145 | 0.350 |
Why?
|
| Lung Injury | 1 | 2012 | 123 | 0.340 |
Why?
|
| Heart-Assist Devices | 7 | 2009 | 1099 | 0.300 |
Why?
|
| Dextrocardia | 1 | 2005 | 9 | 0.230 |
Why?
|
| Heart Failure | 5 | 2009 | 2429 | 0.190 |
Why?
|
| Wounds and Injuries | 2 | 2015 | 394 | 0.180 |
Why?
|
| Multiple Trauma | 1 | 2016 | 63 | 0.120 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2015 | 139 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 144 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2015 | 814 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 226 | 0.100 |
Why?
|
| Clinical Protocols | 1 | 2014 | 243 | 0.100 |
Why?
|
| Monocytes | 1 | 2015 | 349 | 0.100 |
Why?
|
| Pneumonia | 1 | 2016 | 341 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2012 | 33 | 0.100 |
Why?
|
| Heart Transplantation | 4 | 2007 | 887 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2014 | 313 | 0.100 |
Why?
|
| Enteral Nutrition | 1 | 2014 | 269 | 0.100 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2012 | 59 | 0.090 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2012 | 156 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 314 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 294 | 0.080 |
Why?
|
| Intensive Care Units | 1 | 2014 | 539 | 0.080 |
Why?
|
| Myocardium | 2 | 2005 | 907 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2012 | 911 | 0.080 |
Why?
|
| Critical Care | 1 | 2014 | 699 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2014 | 701 | 0.070 |
Why?
|
| Middle Aged | 8 | 2015 | 29081 | 0.070 |
Why?
|
| Male | 11 | 2016 | 65657 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2014 | 503 | 0.070 |
Why?
|
| Diet | 1 | 2014 | 1174 | 0.070 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2006 | 3 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2006 | 93 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1770 | 0.060 |
Why?
|
| Early Ambulation | 1 | 2006 | 9 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2006 | 158 | 0.060 |
Why?
|
| Aged | 6 | 2015 | 21584 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 173 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2005 | 134 | 0.060 |
Why?
|
| Antibody Formation | 1 | 2005 | 275 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2006 | 783 | 0.060 |
Why?
|
| Hypertension, Pulmonary | 1 | 2009 | 477 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2015 | 13101 | 0.060 |
Why?
|
| Brain Death | 1 | 2005 | 75 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 66 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 481 | 0.050 |
Why?
|
| Mast Cells | 1 | 2004 | 76 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2006 | 891 | 0.050 |
Why?
|
| Cell Communication | 1 | 2004 | 190 | 0.050 |
Why?
|
| Obesity | 1 | 2015 | 2438 | 0.050 |
Why?
|
| Ventricular Function | 1 | 2003 | 87 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2005 | 566 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2003 | 338 | 0.040 |
Why?
|
| Comorbidity | 1 | 2005 | 1626 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2003 | 533 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2016 | 439 | 0.040 |
Why?
|
| Humans | 12 | 2015 | 133529 | 0.040 |
Why?
|
| Mice | 2 | 2016 | 18910 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 685 | 0.040 |
Why?
|
| Cytokines | 1 | 2005 | 1381 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1102 | 0.040 |
Why?
|
| Kidney | 1 | 2005 | 1382 | 0.030 |
Why?
|
| Lung | 1 | 2005 | 1574 | 0.030 |
Why?
|
| Animals | 3 | 2016 | 36122 | 0.030 |
Why?
|
| Retrospective Studies | 5 | 2015 | 17579 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 188 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2015 | 94 | 0.030 |
Why?
|
| Injury Severity Score | 1 | 2015 | 231 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 104 | 0.030 |
Why?
|
| Standard of Care | 1 | 2014 | 135 | 0.030 |
Why?
|
| Adult | 5 | 2015 | 31787 | 0.030 |
Why?
|
| Dietary Proteins | 1 | 2014 | 251 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2014 | 327 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2007 | 1584 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 514 | 0.020 |
Why?
|
| Female | 7 | 2015 | 71560 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2006 | 3141 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2006 | 2880 | 0.020 |
Why?
|
| Adolescent | 3 | 2015 | 20605 | 0.020 |
Why?
|
| Decorin | 1 | 2006 | 8 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4826 | 0.020 |
Why?
|
| Polyethylene Terephthalates | 1 | 2005 | 46 | 0.020 |
Why?
|
| Physical Therapy Modalities | 1 | 2006 | 58 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 819 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2006 | 338 | 0.010 |
Why?
|
| Collagen | 1 | 2006 | 311 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2005 | 44 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 130 | 0.010 |
Why?
|
| HSP47 Heat-Shock Proteins | 1 | 2004 | 4 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2005 | 139 | 0.010 |
Why?
|
| Survivors | 1 | 2007 | 358 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2005 | 438 | 0.010 |
Why?
|
| Equipment Design | 1 | 2005 | 598 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2004 | 245 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 231 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2006 | 463 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 7197 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 204 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1586 | 0.010 |
Why?
|
| Risk Factors | 2 | 2009 | 10970 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 517 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 1196 | 0.010 |
Why?
|
| Critical Illness | 1 | 2006 | 630 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 9980 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 542 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2003 | 375 | 0.010 |
Why?
|
| Registries | 1 | 2005 | 1591 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 2649 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2005 | 1912 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 6545 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2007 | 14904 | 0.010 |
Why?
|
| United States | 1 | 2003 | 11761 | 0.000 |
Why?
|
| Child | 1 | 2007 | 25888 | 0.000 |
Why?
|